1 Study Coverage
1.1 Genomic Biomarkers Revenue in Genomic Biomarkers Business (2017-2022) & (US$ Million) Introduction
1.2 Global Genomic Biomarkers Outlook 2017 VS 2022 VS 2028
1.2.1 Global Genomic Biomarkers Market Size for the Year 2017-2028
1.2.2 Global Genomic Biomarkers Market Size for the Year 2017-2028
1.3 Genomic Biomarkers Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Genomic Biomarkers in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Genomic Biomarkers Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Genomic Biomarkers Market Dynamics
1.4.1 Genomic Biomarkers Industry Trends
1.4.2 Genomic Biomarkers Market Drivers
1.4.3 Genomic Biomarkers Market Challenges
1.4.4 Genomic Biomarkers Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Genomic Biomarkers by Type
2.1 Genomic Biomarkers Market Segment by Type
2.1.1 Oncology
2.1.2 Cardiovascular Diseases
2.1.3 Neurological Diseases
2.1.4 Others
2.2 Global Genomic Biomarkers Market Size by Type (2017, 2022 & 2028)
2.3 Global Genomic Biomarkers Market Size by Type (2017-2028)
2.4 United States Genomic Biomarkers Market Size by Type (2017, 2022 & 2028)
2.5 United States Genomic Biomarkers Market Size by Type (2017-2028)
3 Genomic Biomarkers by Application
3.1 Genomic Biomarkers Market Segment by Application
3.1.1 Diagnostic and Research Laboratories
3.1.2 Hospitals
3.1.3 Others
3.2 Global Genomic Biomarkers Market Size by Application (2017, 2022 & 2028)
3.3 Global Genomic Biomarkers Market Size by Application (2017-2028)
3.4 United States Genomic Biomarkers Market Size by Application (2017, 2022 & 2028)
3.5 United States Genomic Biomarkers Market Size by Application (2017-2028)
4 Global Genomic Biomarkers Competitor Landscape by Company
4.1 Global Genomic Biomarkers Market Size by Company
4.1.1 Top Global Genomic Biomarkers Companies Ranked by Revenue (2021)
4.1.2 Global Genomic Biomarkers Revenue by Player (2017-2022)
4.2 Global Genomic Biomarkers Concentration Ratio (CR)
4.2.1 Genomic Biomarkers Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Genomic Biomarkers in 2021
4.2.3 Global Genomic Biomarkers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Genomic Biomarkers Headquarters, Revenue in Genomic Biomarkers Business (2017-2022) & (US$ Million) Type
4.3.1 Global Genomic Biomarkers Headquarters and Area Served
4.3.2 Global Genomic Biomarkers Companies Revenue in Genomic Biomarkers Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Genomic Biomarkers Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Genomic Biomarkers Market Size by Company
4.5.1 Top Genomic Biomarkers Players in United States, Ranked by Revenue (2021)
4.5.2 United States Genomic Biomarkers Revenue by Players (2020, 2021 & 2022)
5 Global Genomic Biomarkers Market Size by Region
5.1 Global Genomic Biomarkers Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Genomic Biomarkers Market Size by Region (2017-2028)
5.2.1 Global Genomic Biomarkers Market Size by Region: 2017-2022
5.2.2 Global Genomic Biomarkers Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Genomic Biomarkers Market Size YoY Growth 2017-2028
6.1.2 North America Genomic Biomarkers Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Genomic Biomarkers Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Genomic Biomarkers Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Genomic Biomarkers Market Size YoY Growth 2017-2028
6.3.2 Europe Genomic Biomarkers Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Genomic Biomarkers Market Size YoY Growth 2017-2028
6.4.2 Latin America Genomic Biomarkers Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Genomic Biomarkers Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Genomic Biomarkers Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Thermo Fisher Scientific
7.1.1 Thermo Fisher Scientific Company Details
7.1.2 Thermo Fisher Scientific Business Overview
7.1.3 Thermo Fisher Scientific Genomic Biomarkers Introduction
7.1.4 Thermo Fisher Scientific Revenue in Genomic Biomarkers Business (2017-2022)
7.1.5 Thermo Fisher Scientific Recent Development
7.2 Roche
7.2.1 Roche Company Details
7.2.2 Roche Business Overview
7.2.3 Roche Genomic Biomarkers Introduction
7.2.4 Roche Revenue in Genomic Biomarkers Business (2017-2022)
7.2.5 Roche Recent Development
7.3 Aepodia
7.3.1 Aepodia Company Details
7.3.2 Aepodia Business Overview
7.3.3 Aepodia Genomic Biomarkers Introduction
7.3.4 Aepodia Revenue in Genomic Biomarkers Business (2017-2022)
7.3.5 Aepodia Recent Development
7.4 Myriad Genetics
7.4.1 Myriad Genetics Company Details
7.4.2 Myriad Genetics Business Overview
7.4.3 Myriad Genetics Genomic Biomarkers Introduction
7.4.4 Myriad Genetics Revenue in Genomic Biomarkers Business (2017-2022)
7.4.5 Myriad Genetics Recent Development
7.5 Eurofins Scientific
7.5.1 Eurofins Scientific Company Details
7.5.2 Eurofins Scientific Business Overview
7.5.3 Eurofins Scientific Genomic Biomarkers Introduction
7.5.4 Eurofins Scientific Revenue in Genomic Biomarkers Business (2017-2022)
7.5.5 Eurofins Scientific Recent Development
7.6 QIAGEN
7.6.1 QIAGEN Company Details
7.6.2 QIAGEN Business Overview
7.6.3 QIAGEN Genomic Biomarkers Introduction
7.6.4 QIAGEN Revenue in Genomic Biomarkers Business (2017-2022)
7.6.5 QIAGEN Recent Development
7.7 Bio-Rad Laboratories
7.7.1 Bio-Rad Laboratories Company Details
7.7.2 Bio-Rad Laboratories Business Overview
7.7.3 Bio-Rad Laboratories Genomic Biomarkers Introduction
7.7.4 Bio-Rad Laboratories Revenue in Genomic Biomarkers Business (2017-2022)
7.7.5 Bio-Rad Laboratories Recent Development
7.8 Genomic Health
7.8.1 Genomic Health Company Details
7.8.2 Genomic Health Business Overview
7.8.3 Genomic Health Genomic Biomarkers Introduction
7.8.4 Genomic Health Revenue in Genomic Biomarkers Business (2017-2022)
7.8.5 Genomic Health Recent Development
7.9 Liquid Genomics
7.9.1 Liquid Genomics Company Details
7.9.2 Liquid Genomics Business Overview
7.9.3 Liquid Genomics Genomic Biomarkers Introduction
7.9.4 Liquid Genomics Revenue in Genomic Biomarkers Business (2017-2022)
7.9.5 Liquid Genomics Recent Development
7.10 Epigenomics
7.10.1 Epigenomics Company Details
7.10.2 Epigenomics Business Overview
7.10.3 Epigenomics Genomic Biomarkers Introduction
7.10.4 Epigenomics Revenue in Genomic Biomarkers Business (2017-2022)
7.10.5 Epigenomics Recent Development
7.11 AROS Applied Biotechnology
7.11.1 AROS Applied Biotechnology Company Details
7.11.2 AROS Applied Biotechnology Business Overview
7.11.3 AROS Applied Biotechnology Genomic Biomarkers Introduction
7.11.4 AROS Applied Biotechnology Revenue in Genomic Biomarkers Business (2017-2022)
7.11.5 AROS Applied Biotechnology Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
